Risks May Outweigh Benefits Of Aspirin Use in Diabetes

1 September 2019

journal article
research article
Published by Ovid Technologies (Wolters Kluwer Health) in The American Journal of Nursing

Vol. 119 (9), 54
https://doi.org/10.1097/01.naj.0000580264.56655.e4

Abstract

According to this study: Aspirin has potential benefits in the primary prevention of cardiovascular disease (CVD) in patients with diabetes, but the risks may outweigh the benefits. The use of low-dose aspirin may need to be individualized, based on a person's risk of CVD and bleeding.

Keywords

CARDIOVASCULAR
BLEEDING
OUTWEIGH BENEFITS
ASPIRIN USE
USE IN DIABETES
BENEFITS OF ASPIRIN

This publication has 1 reference indexed in Scilit:

Aspirin has potential benefits for primary prevention of cardiovascular outcomes in diabetes: updated literature-based and individual participant data meta-analyses of randomized controlled trials
Cardiovascular Diabetology, 2019